Substituted imidazopyrimidines and triazolopyrimidines

US8273752B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Stephan Siegel · Berlin, DE
• Andreas Wilmen
• Susanne Röhrig · Hilden, DE
• Niels Svenstrup · Copenhagen, DK
• Mark Jean Gnoth · Mettmann, DE
• Stefan Heitmeier · Wülfrath, DE
• Ulrich Rester · Wuppertal, DE
• Dmitry Zubov · Remscheid, DE
• Jochen Strayle · Wuppertal, DE
• Michael Sperzel · Wuppertal, DE

Key dates

• Filing date: Mar 4, 2008
• Grant date: Sep 25, 2012
• Expiry date: Oct 19, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to substituted imidazo- and triazolopyrimidines and processes for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of haematological disorders, preferably of leucopenias and neutropenias.